Y-mAbs Therapeutics Inc Investor Relations Material
Latest events
Q4 2024
Y-mAbs Therapeutics Inc
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Y-mAbs Therapeutics Inc
Access all reports
Y-mAbs Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of antibody-based therapies for the treatment of cancer. The company specializes in creating monoclonal antibody treatments that target tumors in pediatric and adult patients. Y-mAbs leverages its expertise in immunotherapies to advance a pipeline of innovative treatments designed to improve survival rates and patient outcomes in oncology. Its focus is primarily on addressing rare and difficult-to-treat cancers. The company is headquartered in New York, New York, and its shares are listed on the NASDAQ.
Key slides for Y-mAbs Therapeutics Inc
Corporate Presentation
Y-mAbs Therapeutics Inc
Corporate Presentation
Y-mAbs Therapeutics Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
YMAB
Country
🇺🇸 United States